Provider review
Corsica Health review
Names what the figure covers, and prices the branded pen beside it for scale.
Both compounded figures are floors with no dose behind them, and the wording promises a plan that may include a GLP-1.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Corsica Health
$149/mo sema · $249/mo tirz, all-inclusive
- Vs median
- $20/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is the plain, unremarkable version of the category done competently, and there is something to be said for that. Two molecules, one figure each, both below the middle of the range, and a clear statement of what the figure covers — consultation, medication, shipping and ongoing support — with no membership charged alongside and no commitment to cancel out of. You can take those two numbers at face value in a way you cannot at most sellers here, because the page names the components rather than leaving you to discover a second charge. Listing the branded pen on the same page is useful context rather than an upsell: it shows the compounded route costing roughly a tenth of the FDA-approved product it substitutes for, which is the trade you are actually making and which most compounded sellers prefer not to display. What is missing is the absence that runs through this whole category. Both compounded figures are floors, and no milligram sits behind either, so if you intend to hold a deliberately small dose you cannot check whether the entry price was set for the amount of drug you plan to take or for several times more. The careful phrasing about treatment that may include a GLP-1 when appropriate is worth reading twice: it is accurate about how prescribing works, and it means the product named on the card is not guaranteed to be the product prescribed.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to know what the figure covers before you sign up, itemized rather than implied
- You want the compounded and the branded route priced on one page so you can see the trade
- You want to cancel without a commitment period standing in the way
Look elsewhere if
- You need a ceiling. Both compounded figures are floors only
- You want to match a price to a milligram. Neither figure carries one
- You want a guarantee of which drug you will receive. The wording stops short of that
What it actually costs
Price as published
Compounded semaglutide from $149.00/mo and compounded tirzepatide from $249.00/mo, with the site stating that plans "include a provider consultation, medication if prescribed, shipping, and ongoing support" and no insurance required · a brand-name semaglutide pre-filled weekly pen is listed alongside them from $1,499.00/mo, which puts the compounded figures in scale against the product they substitute for · cancellation is stated as available at any time with no commitment · both compounded figures are "starting from" and no dose sits behind either, so what quantity of drug the entry price buys is unstated · treatment is described as developed by licensed providers and as one that "may include GLP-1–based medications when appropriate", which stops short of saying a GLP-1 is what a given patient receives
- Vs median
- $20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The figure's components are NAMED — provider consultation, medication if prescribed, shipping and ongoing support — with no membership beside it and cancellation stated as available at any time, so the published number can be taken at face value in a way most of this category's cannot. Listing the branded pen on the same page shows the compounded route costing roughly a tenth of the product it substitutes for. Both figures are floors with no ceiling and no dose behind them, and the wording promises a plan that may include a GLP-1 rather than that one will be prescribed. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The figure's components are named — consultation, medication, shipping and support.
- Both molecules are priced separately, and both sit below the middle of the range.
- The branded pen is priced on the same page, showing what the compounded route replaces.
Pharmacy, labs and oversight
Corsica Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Corsica Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
This is the plain, unremarkable version of the category done competently, and there is something to be said for that. Two molecules, one figure each, both below the middle of the range, and a clear statement of what the figure covers — consultation, medication, shipping and ongoing support — with no membership charged alongside and no commitment to cancel out of. A reader can take those two numbers at face value in a way they cannot at most of the sellers here, because the page names the components rather than leaving a reader to discover a second charge. Listing the branded pen on the same page is a useful piece of context rather than an upsell: it shows the compounded route costing roughly a tenth of the FDA-approved product it substitutes for, which is the trade a reader is actually making and which most compounded sellers prefer not to display. What is missing is the same absence that runs through this whole category. Both compounded figures are floors, and no milligram sits behind either, so a reader intending to hold a deliberately small dose has no way to check whether the entry price was set for the amount of drug they plan to take or for several times more. The careful phrasing about treatment that may include a GLP-1 when appropriate is also worth reading twice: it is accurate about how prescribing works and it means the product named on the card is not guaranteed to be the product prescribed.
The honest cons
Both compounded figures are floors with no ceiling published.
- No dose sits behind either price, so neither can be matched to an amount of drug.
- The wording promises a plan that may include a GLP-1, not that one will be prescribed.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Corsica Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#242 of 373
Ordered with the companies that pay us first, and Corsica Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.